🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 10

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 10 of 20
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 18, 2024 at 10:00 AM#46

Following on from PharmacoVig_BOS — and this may be the naive question:

Was that from a primary source or from a summary of one?

45 18NurseKim_ATL, paul_denver, TinaHashiRN and 42 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Oct 26, 2024 at 7:07 PM#47

Closing the loop on my own question.

Update: the thing I was blaming turned out not to be the cause. Leaving the original post as written rather than editing it, so the mistake stays visible for whoever searches this next.

46 19stefan_berlin, Dr.EM_Chicago, pete_RVA and 43 others
Reply Quote Save Share Report
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Nov 4, 2024 at 4:09 AM#48
HPLC_Greg said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

Correct me if the detail matters more than I have assumed.

47 20ricardo_MIA, BrianDallas92, labquiet_amy and 44 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
KetoKyle
Member
678
3,456
Jul 2024
Utah
Nov 12, 2024 at 1:06 PM#49

Old thread, but it comes up first when you search for this, so it is worth updating. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

48 21Dr.GastroMayo, JakeBK_lifts, DerekSJ_a1c and 45 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Nov 20, 2024 at 9:58 PM#50

Clinical perspective, offered as context rather than as advice. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

Last edited: Nov 20, 2024 at 11:58 PM
20 18Dr.ObesityLA, NurseKim_ATL, paul_denver and 17 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register